Pauline Luk
About Pauline Luk
Pauline Luk is a Senior Research Analyst at Corealis Pharma Inc., where she has worked since 2017. She has extensive experience in the pharmaceutical industry, having held various analytical and research roles over nearly two decades.
Work at Corealis Pharma
Pauline Luk has been employed at Corealis Pharma Inc. since 2017, currently holding the position of Senior Research Analyst. In this role, she utilizes her expertise in analytical method development and validation. Her responsibilities include overseeing research projects and ensuring the accuracy of analytical results. Prior to her current position, she worked as a Research Analyst at Corealis Pharma from 2013 to 2017, where she contributed to various research initiatives.
Previous Experience in Pharmaceutical Industry
Pauline Luk has extensive experience in the pharmaceutical industry, having held various positions across multiple companies. She worked at E-Z-EM Canada / Bracco as a Development and Analytical Validation Specialist from 2012 to 2013. Prior to that, she served as a Research Scientist I at AstraZeneca / Omegachem for one year. Her earlier roles include Analyst II at Uman Pharma Inc. and multiple positions at Merck Frosst, where she gained significant experience in research and analytical chemistry.
Education and Expertise
Pauline Luk holds a Bachelor of Science degree from Concordia University and a Diploma of College Studies (DEC) from Marianopolis College. Her educational background supports her expertise in analytical method development and validation, particularly for solid dosage forms. She possesses strong skills in planning and managing multiple projects simultaneously, demonstrating keen attention to detail throughout her career.
Career Timeline
Pauline Luk's career in the pharmaceutical sector began in 2000 when she worked at Merck Frosst as a Drug Specialist for the Medical School Grant Program. She continued with Merck Frosst in various roles, including Staff Chemist and Research Chemist, until 2008. After that, she transitioned to Uman Pharma Inc. as Analyst II, followed by a position at AstraZeneca / Omegachem. Her journey also includes a year at E-Z-EM Canada / Bracco before returning to Corealis Pharma in 2013.